This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Gw Pharma Limited. Active years: 2017.
Company Filing History:
Years Active: 2017
Title: Erin Rock: Innovator in Cannabinoid Research
Introduction
Erin Rock is a notable inventor based in Guelph, Canada. He has made significant contributions to the field of cannabinoid research, particularly in the therapeutic applications of cannabis compounds. His work focuses on the use of tetrahydrocannabivarin (THCV) for medical purposes.
Latest Patents
Erin Rock holds a patent for the use of tetrahydrocannabivarin in the treatment of nausea and vomiting. This invention relates to the isolation and purification of THCV from cannabis plant extracts. The patent specifically addresses the use of THCV for alleviating nausea and vomiting caused by medications, such as chemotherapeutic agents. He has 1 patent to his name.
Career Highlights
Throughout his career, Erin Rock has worked with prominent companies in the cannabis industry, including GW Pharma Limited and GW Research Limited. His experience in these organizations has allowed him to advance his research and contribute to the development of cannabinoid-based therapies.
Collaborations
Erin has collaborated with several professionals in his field, including Linda Parker and Marnie Duncan. These partnerships have enriched his research and expanded the impact of his work in cannabinoid applications.
Conclusion
Erin Rock is a pioneering inventor whose work in cannabinoid research has the potential to improve treatment options for patients experiencing nausea and vomiting. His contributions to the field are significant and continue to influence the development of therapeutic cannabis applications.